Titin mutations and muscle disease

Dalma Kellermayer, John E. Smith, Hendrikus "Henk" Granzier

Research output: Contribution to journalReview article

1 Citation (Scopus)

Abstract

The introduction of next-generation sequencing technology has revealed that mutations in the gene that encodes titin (TTN) are linked to multiple skeletal and cardiac myopathies. The most prominent of these myopathies is dilated cardiomyopathy (DCM). Over 60 genes are linked to the etiology of DCM, but by far, the leading cause of DCM is mutations in TTN with truncating variants in TTN (TTNtvs) associated with familial DCM in ∼ 20% of the cases. Titin is a large (3–4 MDa) and abundant protein that forms the third myofilament type of striated muscle where it spans half the sarcomere, from the Z-disk to the M-line. The underlying mechanisms by which titin mutations induce disease are poorly understood and targeted therapies are not available. Here, we review what is known about TTN mutations in muscle disease, with a major focus on DCM. We highlight that exon skipping might provide a possible therapeutic avenue to address diseases that arise from TTNtvs.

Original languageEnglish (US)
JournalPflugers Archiv European Journal of Physiology
DOIs
StatePublished - Jan 1 2019

Fingerprint

Connectin
Muscle
Dilated Cardiomyopathy
Muscles
Mutation
Muscular Diseases
Genes
Sarcomeres
Striated Muscle
Myofibrils
Exons
Technology
Therapeutics

Keywords

  • Dilated cardiomyopathy
  • Exon skipping
  • Mutations
  • Titin
  • TTNtv

ASJC Scopus subject areas

  • Physiology
  • Clinical Biochemistry
  • Physiology (medical)

Cite this

Titin mutations and muscle disease. / Kellermayer, Dalma; Smith, John E.; Granzier, Hendrikus "Henk".

In: Pflugers Archiv European Journal of Physiology, 01.01.2019.

Research output: Contribution to journalReview article

@article{8f5809fbb3d2499799aea46bfa331519,
title = "Titin mutations and muscle disease",
abstract = "The introduction of next-generation sequencing technology has revealed that mutations in the gene that encodes titin (TTN) are linked to multiple skeletal and cardiac myopathies. The most prominent of these myopathies is dilated cardiomyopathy (DCM). Over 60 genes are linked to the etiology of DCM, but by far, the leading cause of DCM is mutations in TTN with truncating variants in TTN (TTNtvs) associated with familial DCM in ∼ 20{\%} of the cases. Titin is a large (3–4 MDa) and abundant protein that forms the third myofilament type of striated muscle where it spans half the sarcomere, from the Z-disk to the M-line. The underlying mechanisms by which titin mutations induce disease are poorly understood and targeted therapies are not available. Here, we review what is known about TTN mutations in muscle disease, with a major focus on DCM. We highlight that exon skipping might provide a possible therapeutic avenue to address diseases that arise from TTNtvs.",
keywords = "Dilated cardiomyopathy, Exon skipping, Mutations, Titin, TTNtv",
author = "Dalma Kellermayer and Smith, {John E.} and Granzier, {Hendrikus {"}Henk{"}}",
year = "2019",
month = "1",
day = "1",
doi = "10.1007/s00424-019-02272-5",
language = "English (US)",
journal = "Pflugers Archiv European Journal of Physiology",
issn = "0031-6768",
publisher = "Springer Verlag",

}

TY - JOUR

T1 - Titin mutations and muscle disease

AU - Kellermayer, Dalma

AU - Smith, John E.

AU - Granzier, Hendrikus "Henk"

PY - 2019/1/1

Y1 - 2019/1/1

N2 - The introduction of next-generation sequencing technology has revealed that mutations in the gene that encodes titin (TTN) are linked to multiple skeletal and cardiac myopathies. The most prominent of these myopathies is dilated cardiomyopathy (DCM). Over 60 genes are linked to the etiology of DCM, but by far, the leading cause of DCM is mutations in TTN with truncating variants in TTN (TTNtvs) associated with familial DCM in ∼ 20% of the cases. Titin is a large (3–4 MDa) and abundant protein that forms the third myofilament type of striated muscle where it spans half the sarcomere, from the Z-disk to the M-line. The underlying mechanisms by which titin mutations induce disease are poorly understood and targeted therapies are not available. Here, we review what is known about TTN mutations in muscle disease, with a major focus on DCM. We highlight that exon skipping might provide a possible therapeutic avenue to address diseases that arise from TTNtvs.

AB - The introduction of next-generation sequencing technology has revealed that mutations in the gene that encodes titin (TTN) are linked to multiple skeletal and cardiac myopathies. The most prominent of these myopathies is dilated cardiomyopathy (DCM). Over 60 genes are linked to the etiology of DCM, but by far, the leading cause of DCM is mutations in TTN with truncating variants in TTN (TTNtvs) associated with familial DCM in ∼ 20% of the cases. Titin is a large (3–4 MDa) and abundant protein that forms the third myofilament type of striated muscle where it spans half the sarcomere, from the Z-disk to the M-line. The underlying mechanisms by which titin mutations induce disease are poorly understood and targeted therapies are not available. Here, we review what is known about TTN mutations in muscle disease, with a major focus on DCM. We highlight that exon skipping might provide a possible therapeutic avenue to address diseases that arise from TTNtvs.

KW - Dilated cardiomyopathy

KW - Exon skipping

KW - Mutations

KW - Titin

KW - TTNtv

UR - http://www.scopus.com/inward/record.url?scp=85064222402&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85064222402&partnerID=8YFLogxK

U2 - 10.1007/s00424-019-02272-5

DO - 10.1007/s00424-019-02272-5

M3 - Review article

C2 - 30919088

AN - SCOPUS:85064222402

JO - Pflugers Archiv European Journal of Physiology

JF - Pflugers Archiv European Journal of Physiology

SN - 0031-6768

ER -